InsightRX specializes in model-informed precision dosing and clinical decision support systems to enhance patient outcomes in healthcare. The company provides real-time clinical analytics and therapeutic methodologies for various medical disciplines.

InsightRX

InsightRX empowers life science and provider healthcare organizations to individualize treatment from clinical development to the point of care.

Comet Labs

OSF Ventures

FundersClub

GreatPoint Ventures

Leawood Venture Capital

Rock Health Capital

OSF Healthcare System

HealthX Ventures

Premier

The InsightRX team is looking forward to the ASHP Midyear 2023 conference in Anaheim, California, from Dec. 3-7. Just in time for #ASHP23, we’re announcing three major enhancements to our current precision dosing solutions based on recent scientific and technological breakthroughs.

☑ A more accurate vancomycin PK dosing model for adult patients
☑ An exclusive MIPD feature enabling more accurate predictions
☑ A new model for adult vancomycin patients with Class III obesity

Drop in to visit us at Booth 566 during #ASHP23 to meet the team and discuss how these exciting new breakthroughs will enable clinicians to provide vancomycin patients with highly accurate and individualized doses to ensure safety and efficacy: https://bit.ly/3sULQaY | #PrecisionMedicine #PrecisionDosing #Vancomycin #ImagineThePossiblities

New laws leave consumers unprotected against third parties accessing their genetic data, according to the authors of an analysis published by JAMA Network Open.

“The bottom line is that ultimately more needs to be done in this space to protect consumers, according to the commentary. The enacted legislation does not robustly address the fact that third parties, particularly law enforcement and insurers, can still access and use consumer genetic data.”

https://bit.ly/47ixcci | #GeneticData #HealthData Applied Clinical Trials Magazine MJH Life Sciences®

Mark your calendar for this upcoming ASCPT Webinar on Friday, Dec 8, 2023, at 2:00 PM ET titled, “Establishing a Framework for Precision Dosing in a Clinical Trial.”

The InsightRX team will highlight two real-life examples:
1️⃣ The use of precision dosing to enable conditioning prior to gene therapy
2️⃣ Precision dosing as a method for selecting the right dose in a vulnerable patient population

Register now to discover how precision dosing and advanced conditioning methods in easy-to-use software enable more effective, personalized treatments.

https://bit.ly/3uojkyJ | #PrecisionMedicine #PrecisionDosing #ClinicalTrials #ASCPT American Society for Clinical Pharmacology & Therapeutics

The InsightRX Team would like to wish you a safe and Happy Thanksgiving! We are grateful for all the clinicians working today and every day to keep their patients safe. #HappyThanksgiving #Grateful #Thankful

Triazole antifungal medications, such as fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, are frequently employed in clinical settings for the treatment of invasive fungal infections. The variability in their pharmacokinetics, documented drug interactions, and established connections between drug exposure and response necessitate the need for therapeutic drug monitoring (TDM) for most triazole antifungals.

This article, representing the Society of Infectious Diseases Pharmacists (SIDP), presents an in-depth discussion of the pharmacokinetic principles and pharmacodynamic targets associated with commonly used triazole antifungals, highlighting the rationale for incorporating TDM for each of these agents.

For example, the consensus guidelines listed in Table 1 suggest Bayesian MIPD should be used for adjusting voriconazole.

Read more: https://bit.ly/492qPeO | #AntifungalMedications #Pharmacokinetics #TherapeuticDrugMonitoring

COM:INSIGHT-RX

InsightRX

Analysis Not Available